MoCRA in Practice
05/05/2026
How FDA Is Implementing Its Expanded Cosmetics Authority—and What It Means for Industry
How FDA Is Implementing Its Expanded Cosmetics Authority—and What It Means for Industry
What They Are, How to Avoid Them, and How to Mitigate Successfully
Forever Chemicals, Federal Oversight, and the Changing Regulatory Landscape
On March 11, 2026, the U.S. Food and Drug Administration (FDA) announced the launch of the Adverse Event Monitoring System (AEMS), a centralized, AI-driven platform
FDA’s Valentine’s Day Reminder for OTC Drug Claims
The Ongoing Impact of the Government Shutdown on FDA and Regulated Industry — and What Companies Should Prioritize
